About this trial
In the proposed study, three objectives will be pursued:
1. To develop a method to identify more effectively the acute and long-term risk of adolescents with the most threatening self-harm behaviours. 2. To identify the factors that influence the risk of self-harm behaviours and the success of treatment/treatment of these behaviours in the most at-risk adolescents (changes in these factors). 3. Develop guidelines for more effective treatment of the most at-risk adolescents.
For this purpose, a sample of approximately 200 young people who will be hospitalised for suicide risk (the most at risk in Slovenia) and an approximately equal number of healthy adolescents will be included. At inclusion, the presence of several factors will be assessed by reviewing demographic data, clinical diagnosis, self-assessment questionnaires and clinical psychological tests (CSSRS, B-NSSI-AT, ISAS, LPFS-BF2.0, BPFSC-11, TSCC, PAI, ECR-RS, DASA-YV, ASHRS), social assessment, and blood sampling for genetic analyses (DNA isolation, sequencing, nucleotide sequence recognition, quantification and evaluation of short tandem repeats, identification of methylation sites). Longitudinal tracking of autoaggressive events and heteroaggressive events during hospitalisation will be performed and recorded on an ongoing basis. The risk and protective factors of the adolescents most at risk will be compared with a control group of adolescents. The same factors will be reassessed in the most at-risk adolescents after 6 and 18 months of treatment as usual. The data will be collected in a data entry and storage system that will ensure the privacy of the data entered in accordance with the GDPR.
This will allow the investigators to identify young people at particular risk of severe self-harm behaviour more reliably, to target them for more intensive and effective treatment, and thus to improve their safety, quality of life and prognosis in the short and long term.
Eligibility criteria
Qualifiers
Suicidality
Self-harming with no intention to die
Disqualifiers
Confirmed acute psychotic disorder
Intellectual disability
Severe physical illness (e.g. cardiovascular or renal disease)
Disease of the central nervous system (e.g. encephalitis, brain injury or haemorrhage, epilepsy)
Trial design
Treatments tested in this trial
- Enrollment questionnaire, General questionnaire1, General questionnaire2, General questionnaire3
- Columbia Suicide Severity Rating Scale (CSSRS)
- The Brief Non-Suicidal Self-Injury Assessment Tool (B-NSSI-AT)
- Experiences in Close Relationships-Relationship Structures (ECR-RS)
- Trauma Symptom Checklist for Children (TSCC)
- Personality Assessment Inventory-Adolescent (PAI-A)
- Inventory Of Statements About Self-Injury; ISAS
- The Level of Personality Functioning Scale-Brief Form 2.0; LPFSBF 2.0
- Borderline Personality Features Scale, BPFSC-11
- Dynamic Appraisal of Situational Aggression-Youth Version (DASA-YV)
- Adolescent Self-Harm Risk Scale; ASHRS
- Lifetime Incidence of Traumatic Events questionnaire (LITE)
- Genetic methods
Treatment groups
Sponsors and collaborators
University of Ljubljana, Faculty of Medicine
Lead sponsor
University Medical Centre Ljubljana
Collaborator
University Maribor
Collaborator
University Psychiatric Clinic Ljubljana
Collaborator